• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Novel procedure for rapid pharmacokinetic screening of discovery compounds in rats.

作者信息

Cox KA, Dunn-Meynell K, Korfmacher WA, Broske L, Nomeir AA, Lin CC, Cayen MN, Barr WH

机构信息

Department of Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033-0539, USA.

出版信息

Drug Discov Today. 1999 May;4(5):232-237. doi: 10.1016/s1359-6446(98)01299-9.

DOI:10.1016/s1359-6446(98)01299-9
PMID:10322290
Abstract

In therapeutic areas aimed at developing an orally administered drug, the pharmacokinetic profile of a drug candidate after oral administration in vivo is pivotal in evaluating its success. This can be done by monitoring the plasma concentration versus time after dosing and calculating the area under the curve (AUC). The authors describe a novel screening protocol in which an estimated AUC can be determined, allowing the rapid evaluation of large numbers of compounds and providing a rank order of estimated AUC values to prioritize compounds for further investigation.

摘要

相似文献

1
Novel procedure for rapid pharmacokinetic screening of discovery compounds in rats.
Drug Discov Today. 1999 May;4(5):232-237. doi: 10.1016/s1359-6446(98)01299-9.
2
Rapid in vivo oral screening in rats: reliability, acceptance criteria, and filtering efficiency.大鼠体内快速口服筛选:可靠性、验收标准和筛选效率。
AAPS J. 2006 Jul 28;8(3):E493-500. doi: 10.1208/aapsj080358.
3
Development of a high-throughput in vitro assay using a novel Caco-2/rat hepatocyte system for the prediction of oral plasma area under the concentration versus time curve (AUC) in rats.
J Pharmacol Toxicol Methods. 2006 May-Jun;53(3):215-8. doi: 10.1016/j.vascn.2005.08.002. Epub 2005 Sep 21.
4
Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice.评估盒式给药法在小鼠中评估格尔德霉素类似物药代动力学的应用。
Cancer Chemother Pharmacol. 2004 Dec;54(6):475-86. doi: 10.1007/s00280-004-0853-7. Epub 2004 Jul 29.
5
An efficient approach for the rapid assessment of oral rat exposures for new chemical entities in drug discovery.一种用于药物研发中新型化学实体大鼠口服暴露快速评估的有效方法。
J Pharm Sci. 2006 Aug;95(8):1684-92. doi: 10.1002/jps.20642.
6
Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models.卡马西平及其九种衍生物的药代动力学、脑分布和血浆蛋白结合:用于预测性计算 ADME 模型的新数据集。
Epilepsy Res. 2013 Nov;107(1-2):37-50. doi: 10.1016/j.eplepsyres.2013.08.013. Epub 2013 Sep 3.
7
A limited sampling strategy for estimation of the cladribine plasma area under the concentration versus time curve after intermittent i.v. infusion, s.c. injection, and oral administration.一种用于估算间歇性静脉输注、皮下注射和口服给药后克拉屈滨血药浓度-时间曲线下面积的有限采样策略。
Cancer Chemother Pharmacol. 1996;38(6):536-40. doi: 10.1007/s002800050523.
8
The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat.全反式维甲酸的浓度-时间曲线下面积是该类视黄醇在大鼠体内胚胎毒性最适宜的药代动力学相关指标。
Toxicol Appl Pharmacol. 1997 Apr;143(2):436-44. doi: 10.1006/taap.1997.8105.
9
Pharmacokinetic theory of cassette dosing in drug discovery screening.药物发现筛选中盒式给药的药代动力学理论。
Drug Metab Dispos. 2001 Jul;29(7):957-66.
10
Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.随机试验中口服溶液与普通片的双氯芬酸钾的药代动力学差异:进食与禁食状态的影响。
Headache. 2015 Feb;55(2):265-75. doi: 10.1111/head.12483. Epub 2014 Dec 24.

引用本文的文献

1
Survival-Assured Liver Injury Preconditioning (SALIC) Enables Robust Expansion of Human Hepatocytes in Fah Rag2 IL2rg Rats.生存保障型肝损伤预处理 (SALIC) 可使 Fah Rag2 IL2rg 大鼠中的人肝细胞大量扩增。
Adv Sci (Weinh). 2021 Oct;8(19):e2101188. doi: 10.1002/advs.202101188. Epub 2021 Aug 11.
2
Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.NCATS 大鼠肝微粒体稳定性的回顾性评估:数据和 QSAR 模型。
Sci Rep. 2020 Nov 26;10(1):20713. doi: 10.1038/s41598-020-77327-0.
3
Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of Asthma.
用于治疗哮喘的强效选择性CRTh2受体拮抗剂MK-8318的发现。
ACS Med Chem Lett. 2018 Jun 23;9(7):679-684. doi: 10.1021/acsmedchemlett.8b00145. eCollection 2018 Jul 12.
4
Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists.大麻素CB2受体反向激动剂的生物学特性与治疗潜力
Br J Pharmacol. 2008 Jan;153(2):226-39. doi: 10.1038/sj.bjp.0707480. Epub 2007 Oct 1.
5
Rapid in vivo oral screening in rats: reliability, acceptance criteria, and filtering efficiency.大鼠体内快速口服筛选:可靠性、验收标准和筛选效率。
AAPS J. 2006 Jul 28;8(3):E493-500. doi: 10.1208/aapsj080358.
6
The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens.使用自杀性细胞色素P450抑制剂ABT在体内药代动力学筛选中区分吸收和代谢过程。
Eur J Drug Metab Pharmacokinet. 2005 Jan-Jun;30(1-2):75-83. doi: 10.1007/BF03226411.
7
Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?药物研发中药代动力学参数的异速生长标度:能否根据大鼠体内数据预测人体的清除率(CL)、稳态分布容积(Vss)和半衰期(t1/2)?
Eur J Drug Metab Pharmacokinet. 2004 Apr-Jun;29(2):133-43. doi: 10.1007/BF03190588.
8
Application of parallel liquid chromatography/mass spectrometry for high throughput microsomal stability screening of compound libraries.平行液相色谱/质谱联用技术在化合物库高通量微粒体稳定性筛选中的应用。
J Am Soc Mass Spectrom. 2002 Feb;13(2):155-65. doi: 10.1016/S1044-0305(01)00342-7.